[5-alpha-reductase inhibitors].
A reflection is made, on the one hand, on the lack of correlation between the intensity of micturition problems and the volume of the prostate and, on the other hand, on the different therapeutic approaches of irritative or obstructive voiding problems, and finally on the insufficiently convincing activity of Finasteride.
De Jaegher
K
K
Kozyreff
P
P
Claes
H
H
D058891:5-alpha Reductase Inhibitors; D013196:Dihydrotestosterone / Q000378:metabolism; D018120:Finasteride / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011467:Prostate / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000378:metabolism
D058891:5-alpha Reductase Inhibitors; D013196:Dihydrotestosterone; D018120:Finasteride